HIGHLIGHTS
- who: Jana Ihlow and colleagues from the Institute of Pathology, Charitu00e9-Universitu00e4tsmedizin Berlin, Corporate Member of Freie Universitu00e4t Berlin and Humboldt-Universitu00e4t zu Berlin, Charitu00e9platz, Berlin, Germany Institute of Pathology, Philipps-University Marburg, Baldingerstrau00dfe, Marburg, Germany have published the article: Low Expression of RGS2 Promotes Poor Prognosis in High-Grade Serous Ovarian Cancer, in the Journal: (JOURNAL) of 31/Dec/2019
- what: The authors characterized the expression of RGS2 and its relation to prognosis in HGSOC on the protein level by immunohistochemistry in 519 patients treated at on the mRNA level in 299 cases from . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.